Copper(I)-catalyzed highly efficient synthesis of benzoselenazoles and benzotellurazoles

Journal of Organic Chemistry

Volumn 72, Issue 21, 2007, Pages 8087-8090

  Fujiwara, Shin Ichi ^a   Asanuma, Yoshiaki ^b   Shin ike, Tsutomu ^a   Kambe, Nobuaki ^b  

^a OSAKA DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROATOM SUBSTITUENT; ISOCYANIDES;

CATALYSIS; COPPER; NUCLEOPHILES; SYNTHESIS (CHEMICAL);

AROMATIC COMPOUNDS;

2 AMINO 1,3 BENZOTELLURAZOLE DERIVATIVE; BENZENE DERIVATIVE; BROMINE DERIVATIVE; COPPER DERIVATIVE; PHENYL GROUP; PYRROLE DERIVATIVE; SELENAZOLE DERIVATIVE; SELENIUM DERIVATIVE; TELLURIUM DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; REACTION ANALYSIS; SYNTHESIS;

AZOLES; BENZENE DERIVATIVES; CATALYSIS; COPPER; MOLECULAR STRUCTURE; ORGANOSELENIUM COMPOUNDS; TELLURIUM;

EID: 35348854372     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo7013164     Document Type: Article

References (60)

1. For recent examples: (a) Mortimer, C. G.; Wells, G.; Crochard, J.-P.; Stone, E. L.; Bradshaw, T. D.; Stevens, M. F. G.; Westwell, A. D. J. Med. Chem. 2006, 49, 179-185.
2. (b) Brantley, E.; Antony, S.; Kohlhagen, G.; Meng, L.-H.; Agama, K.; Stinton, S. F.; Sausville, E. A.; Pommier, Y. Cancer Chemother. Pharmacol. 2006, 58, 62-72.
3. (c) Ryu, C.-K.; Han, J.-Y.; Jung, O.-J.; Lee, S.-K.; Lee, J. Y.; Jeong, S. H. Bioorg. Med. Chem. Lett. 2005, 15, 679-682.
4. (d) Bradshaw, T. D.; Westwell, A. D. Curr. Med. Chem. 2004, 11, 1009-1021.
5. (e) Mathis, C. A.; Wang, Y.; Holt, D. P.; Huang, G.-F.; Debnath, M. L.; Klunk, W. E. J. Med. Chem. 2003, 46, 2740-2754.
6. (f) Kočí, J.; Klimešová, V.; Waisser, K.; Kaustová, J.; Dahse, H.-M.; Möllmann, U. Bioorg. Med. Chem. Lett. 2002, 12, 3275-3278.
7. (g) Mouri, T.; Tokumura, J.; Kochi, S.; Fukui, H.; Nakano, J.; Ando, T.; Hori, M. J. Pesticide Sci. 2002, 27, 353-359.
8. (h) Phoon, C. W.; Ng, P. Y.; Ting, A. E.; Yeo, S. L.; Sim, M. M. Bioorg. Med. Chem. Lett, 2001, 11, 1647-1650.
9. (i) Hutchinson, I.; Chua, M.-S.; Browne, H. L.; Trapani, V.; Bradshaw, T. D.; Westwell, A. D.; Stevens, M. F. C. J. Med. Chem. 2001, 44, 1446-1455.
10. (j) Bradshaw, T. D.; Stevens, M. F. G.; Westwell, A. D. Curr. Med. Chem. 2001, 8, 203-210.
11. (k) Oketani, K.; Inoue, T.; Murakami, M. Eur. J. Pharmacol. 2001, 427, 159-166.
12. For recent examples: (a) Santos, P. F.; Reis, L. V.; Almeida, P.; Serrano, J. P.; Oliveira, A. S.; Ferreira, L. F. V. J. Photochem. Photobiol. A 2004, 163, 267-269.
13. (b) Santos, P. F.; Reis, L. V.; Almeida, P.; Oliveira, A. S.; Ferreira, L. F. V. J. Photochem. Photobiol. A 2003, 160, 159-161.
14. (c) Reis, L. V.; Serrano, J. P. C.; Almeida, P.; Santos, P. F. Synlett 2002, 1617-1620.
15. Costa, S. P. G.; Ferreira, J. A.; Kirsch, G.; Oliveira-Campos, A. M. F. J. Chem. Res. 1997, 314-315.
16. Heynderickx, A.; Guglielmetti, R.; Dubest, R.; Aubard, J.; Samat, A. Synthesis 2003, 1112-1116.
17. For very recent examples: (a) Kawashita, Y.; Ueba, C.; Hayashi, M. Tetrahedron Lett. 2006, 47, 4231-4233.
18. (b) Heo, Y.; Song, Y. S.; Kim, B. T.; Heo, J.-N. Tetrahedron Lett. 2006, 47, 3091-3094.
19. (c) Li, Y.; Wang, Y.-L.; Wang, J.-Y. Chem. Lett. 2006, 35, 460-461.
20. (d) Evinder, G.; Batey, R. A. J. Org. Chem. 2006, 71, 1802-1808.
21. (e) Joyce, L. L.; Evindar, G.; Batey, R. A. Chem. Commun. 2004, 446-447.
22. For a review: Ulrich, H. In Science of Synthesis: Hetarenes and Related Ring Systems. Five-Membered Hetarenes with One Chalcogen and One Additional Heteroatom; Schaumann, E., Ed.; George Thieme Verlag: Stuttgart, Germany, 2002; Vol. 11, pp 835-912.
23. Reviews for pharmacological activities of selenium-containing heterocycles: (a) Nogueira, C. W.; Zeni, G.; Rocha, J. B. T. Chem. Rev. 2004, 104, 6255-6286.
24. (b) Mugesh, G.; du Mont, W.-W.; Sies, H. Chem. Rev. 2001, 101, 2125-2180.
25. For biological activities of 1,3-selenazoles: (a) Sekiguchi, A.; Nishina, A.; Kimura, H.; Fukumoto, R.; Kanoh, K.; Ishihara, H.; Koketsu, M. Chem. Pharm. Bull. 2005, 53, 1439-1442.
26. (b) Koketsu, M.; Choi, S. Y.; Ishihara, H.; Lim, B. O.; Kim, H.; Kim, S. Y. Chem. Pharm. Bull. 2002, 50, 1594-1596.
27. (c) Li, H.; Hallows, W. H.; Punzi, J. S.; Marquez, V. E.; Carrell, H. L.; Pankiewicz, K. W.; Watanabe, K. A.; Goldstein, B. M. Biochemistry 1994, 33, 23-32.
28. (d) Goldstein, B. M.; Leary, J. F.; Farley, B. A.; Marquez, V. E.; Levy, P. C.; Rowley, P. T. Blood 1991, 78, 593-598.
29. For recent examples of the synthesis of 1,3-selenazoles: (a) Narender, M.; Reddy, M. S.; Kumar, V. P.; Reddy, V. P.; Nageswar, Y. V. D.; Rao, K. R. J. Org. Chem. 2007, 72, 1849-1851.
30. (b) Koketsu, M.; Kanoh, K.; Ando, H.; Ishihara, H. Heteroatom Chem. 2006, 17, 88-92.
31. (c) Below, H.; Pfeiffer, W.-D.; Geisler, K.; Lalk, M.; Langer, P. Eur. J. Org. Chem. 2005, 3637-3639.
32. (d) Koketsu, M.; Tanaka, H.; Ishihara, H. Chem. Lett. 2005, 34, 1260-1261.
33. (e) Geisler, K.; Pfeiffer, W.-D.; Künzler, A.; Below, H.; Bulka, E.; Langer, P. Synthesis 2004, 875-884.
34. (f) Geisler, K.; Künzler, A.; Below, H.; Bulka, E.; Pfeiffer, W.-D.; Langer, P. Synthesis 2004, 97-105.
35. (g) Geisler, K.; Pfeiffer, W.-D.; Müller, C.; Nobst, E.; Bulka, E.; Langer, P. Synthesis 2003, 1215-1220.
36. (h) Geisler, K.; Künzler, A.; Below, H.; Bulka, E.; Pfeiffer, W.-D.; Langer, P. Synlett 2003, 1195-1197.
37. (i) Zhang, P.-F.; Chen, Z.-C. Synthesis 2000, 1219-1222.
38. (j) Maeda, H.; Kambe, N.; Sonoda, N.; Fujiwara, S.; Shin-ike, T. Tetrahedron 1997, 53, 13667-13680.
39. For reviews: (k) Pfeiffer, W.-D. In Science of Synthesis: Hetarenes and Related Ring Systems. Five-Membered Hetarenes with One Chalcogen and One Additional Heteroatom; Schaumann, E., Ed.; George Thieme Verlag: Stuttgart, Germany, 2002; Vol. 11, pp 941-989.
40. (l) Larsen, R. D. In Comprehensive Heterocyclic Chemistry II; Shinkai, I., Ed.; Pergamon: New York, 1996; Vol. 3, pp 493-510.
41. Pfeiffer, W.-D. In Science of Synthesis: Hetarenes and Related Ring Systems. Five-Membered Hetarenes with One Chalcogen and One Additional Heteroatom; Schaumann, E., Ed.; George Thieme Verlag: Stuttgart, Germany, 2002; Vol. 11, pp 991-999.
42. For example: Bogert, M. T.; Stall, A. J. Am. Chem. Soc. 1927, 49, 2011-2016.
43. Isocyanides are known to react with selenium and secondary amines in the presence of a base to give selenoureas: (a) Bulka, E.; Ahlers, K. D.; Tucek, E. Chem. Ber. 1967, 100, 1367-1372.
44. (b) Sonoda, N.; Yamamoto, G.; Tsutsumi, S. Bull. Chem. Soc. Jpn. 1972, 45, 2937-2938.
45. See also: (c) Fujiwara, S.; Matsuya, T.; Maeda, H.; Shin-ike, T.; Kambe, N.; Sonoda, N. Synlett 1999, 75-76.
46. The radical cyclization mechanism may be ruled out since when we performed the reaction in the presence of TEMPO, radical scavenger, no radical species were trapped with TEMPO and 3a was formed quantitatively.
47. The oxidative addition mechanism was proposed in 2-aminothiazole synthesis by copper- and palladium-catalyzed intramolecular coupling reaction of o-haloarylthioureas, see ref 5e.
48. For earlier work on nickel-catalyzed coupling of vinyl sulfides with Grignard reagents: Okamura, H.; Miura, M.; Takei, H. Tetrahedron Lett. 1979, 43-46.
49. For the synthesis of the related 2-aryl-1,3-benzothiazoles: (a) Bose, D. S.; Idrees, M. J. Org. Chem. 2006, 71, 8261-8263.
50. (b) Ben-Alloum, A.; Bakkas, S.; Soufiaoui, M. Tetrahedron Lett. 1997, 38, 6395-6396.
51. (c) Shi, D.-F.; Bradshaw, T. D.; Wrigley, S.; McCall, C. J.; Lelieveld, P.; Fichtner, I.; Stevens, M. F. G. J. Med. Chem. 1996, 39, 3375-3384.
52. Pfeiffer, W.-D. In Science of Synthesis: Hetarenes and Related Ring Systems. Five-Membered Hetarenes with One Chalcogen and One Additional Heteroatom; Schaumann, E., Ed.; George Thieme Verlag: Stuttgart, Germany, 2002; Vol. 11, pp 1005-1020.
53. Usagawa, Y.; Sakamoto, H.; Yamashita, K. Jpn. Kokai Tokkyo Koho 1987, 18;
54. Chem. Abstr. 1987, 109, 29967.
55. Inoue, T.; Mogami, T.; Kambe, N.; Ogawa, A.; Sonoda, N. Heteroatom Chem. 1993, 4, 471-474.
56. Maeda, H.; Matsuya, T.; Kambe, N.; Sonoda, N.; Fujiwara, S.; Shinike, T. Tetrahedron 1997, 53, 12159-12166.
57. The present transformation is not affected by the amounts of CuI and additive very much. When the reactions were carried out by using 3 mol % of CuI or without HMPA, 12a was obtained in 69% and 70% NMR yields, respectively.
58. For 2-amino-1,3-benzoselenazoles, see: (a) Lok, R.; Leone, R. E.; Williams, A. J. J. Org. Chem. 1996, 61, 3289-3297.
59. (b) Duddeck, H.; Bradenahl, R.; Stefaniak, L.; Jazwinski, J.; Kamienski, B. Magn. Reson. Chem. 2001, 39, 709-713.
60. 4 with aromatic ureas, see ref 18.